1 asset in Neurofibrosarcoma
Therapeutic assets addressing Neurofibrosarcoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Nivolumab Neurofibrosarcoma | Instituto do Cancer do Estado de São Paulo | P2 | CCC (53) |